Jane Street’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $36.5M | Sell |
661,399
-411,956
| -38% | -$22.3M | ﹤0.01% | 1272 |
|
|
2025
Q4 | $52.6M | Sell |
1,073,355
-555,568
| -34% | -$25.9M | 0.01% | 909 |
|
|
2025
Q3 | $70.3M | Sell |
1,628,923
-240,026
| -13% | -$9.38M | 0.01% | 769 |
|
|
2025
Q2 | $71.8M | Buy |
1,868,949
+330,319
| +21% | +$12.6M | 0.01% | 589 |
|
|
2025
Q1 | $59.6M | Buy |
1,538,630
+475,823
| +45% | +$17.4M | 0.02% | 571 |
|
|
2024
Q4 | $35.9M | Buy |
1,062,807
+810,335
| +321% | +$29.2M | 0.01% | 871 |
|
|
2024
Q3 | $10.3M | Sell |
252,472
-225,993
| -47% | -$9.25M | ﹤0.01% | 1876 |
|
|
2024
Q2 | $18.4M | Buy |
478,465
+349,828
| +272% | +$14.7M | ﹤0.01% | 1390 |
|
|
2024
Q1 | $5.51M | Sell |
128,637
-324,300
| -72% | -$13.4M | ﹤0.01% | 2484 |
|
|
2023
Q4 | $16.8M | Buy |
452,937
+370,853
| +452% | +$13.3M | ﹤0.01% | 1423 |
|
|
2023
Q3 | $2.98M | Buy |
82,084
+26,059
| +47% | +$925K | ﹤0.01% | 3388 |
|
|
2023
Q2 | $1.98M | Sell |
56,025
-78,092
| -58% | -$2.8M | ﹤0.01% | 4179 |
|
|
2023
Q1 | $4.77M | Sell |
134,117
-1,691,960
| -93% | -$59.2M | ﹤0.01% | 2537 |
|
|
2022
Q4 | $63.5M | Buy |
1,826,077
+1,692,750
| +1,270% | +$56.4M | 0.03% | 431 |
|
|
2022
Q3 | $3.88M | Buy |
133,327
+18,435
| +16% | +$699K | ﹤0.01% | 3021 |
|
|
2022
Q2 | $6.25M | Sell |
114,892
-407,786
| -78% | -$22.5M | ﹤0.01% | 2339 |
|
|
2022
Q1 | $28.5M | Buy |
522,678
+439,754
| +530% | +$23.9M | 0.01% | 1003 |
|
|
2021
Q4 | $4.57M | Buy |
+82,924
| New | +$4.31M | ﹤0.01% | 3009 |
|
|
2021
Q3 | – | Sell |
-101,323
| Closed | -$5.09M | – | 10231 |
|
|
2021
Q2 | $5.04M | Sell |
101,323
-29,665
| -23% | -$1.43M | ﹤0.01% | 2613 |
|
|
2021
Q1 | $5.84M | Sell |
130,988
-275,339
| -68% | -$12.5M | ﹤0.01% | 2179 |
|
|
2020
Q4 | $18.7M | Sell |
406,327
-704,419
| -63% | -$32.4M | 0.01% | 910 |
|
|
2020
Q3 | $52.3M | Buy |
1,110,746
+967,190
| +674% | +$48.5M | 0.03% | 377 |
|
|
2020
Q2 | $7.32M | Buy |
143,556
+116,198
| +425% | +$5.96M | 0.01% | 1432 |
|
|
2020
Q1 | $1.29M | Sell |
27,358
-1,397,952
| -98% | -$74.6M | ﹤0.01% | 2507 |
|
|
2019
Q4 | $83.7M | Sell |
1,425,310
-575,847
| -29% | -$32M | 0.12% | 113 |
|
|
2019
Q3 | $107M | Buy |
2,001,157
+548,018
| +38% | +$28.2M | 0.18% | 85 |
|
|
2019
Q2 | $72.7M | Buy |
1,453,139
+1,426,923
| +5,443% | +$71.6M | 0.13% | 108 |
|
|
2019
Q1 | $1.37M | Sell |
26,216
-900,416
| -97% | -$45M | ﹤0.01% | 2439 |
|
|
2018
Q4 | $44.3M | Sell |
926,632
-168,786
| -15% | -$8.31M | 0.09% | 153 |
|
|
2018
Q3 | $55M | Sell |
1,095,418
-183,514
| -14% | -$9.32M | 0.11% | 117 |
|
|
2018
Q2 | $64.4M | Buy |
1,278,932
+1,195,197
| +1,427% | +$60.2M | 0.15% | 87 |
|
|
2018
Q1 | $4.09M | Sell |
83,735
-39,887
| -32% | -$1.86M | 0.01% | 1132 |
|
|
2017
Q4 | $5.48M | Buy |
+123,622
| New | +$5.71M | 0.02% | 815 |
|
|
2017
Q3 | – | Sell |
-611,739
| Closed | -$31M | – | 4678 |
|
|
2017
Q2 | $33M | Buy |
+611,739
| New | +$32.6M | 0.12% | 156 |
|
|
2016
Q4 | – | Sell |
-11,974
| Closed | -$591K | – | 4238 |
|
|
2016
Q3 | $646K | Sell |
11,974
-7,120
| -37% | -$390K | ﹤0.01% | 2481 |
|
|
2016
Q2 | $1.03M | Sell |
19,094
-1,389,431
| -99% | -$73.2M | 0.01% | 1942 |
|
|
2016
Q1 | $71.4M | Sell |
1,408,525
-302,288
| -18% | -$15.1M | 0.4% | 40 |
|
|
2015
Q4 | $86.3M | Buy |
1,710,813
+954,227
| +126% | +$48.6M | 0.54% | 28 |
|
|
2015
Q3 | $36.4M | Buy |
756,586
+84,610
| +13% | +$4.4M | 0.23% | 73 |
|
|
2015
Q2 | $35M | Buy |
671,976
+664,974
| +9,497% | +$37.4M | 0.23% | 57 |
|
|
2015
Q1 | $404K | Sell |
7,002
-1,448,963
| -100% | -$83.1M | ﹤0.01% | 2251 |
|
|
2014
Q4 | $77.8M | Buy |
+1,455,965
| New | +$81.5M | 0.59% | 25 |
|
|
2014
Q1 | – | Sell |
-31,373
| Closed | -$2.09M | – | 2823 |
|
|
2013
Q4 | $2.09M | Sell |
31,373
-215,530
| -87% | -$14M | 0.03% | 452 |
|
|
2013
Q3 | $15.5M | Buy |
246,903
+21,325
| +9% | +$1.37M | 0.18% | 86 |
|
|
2013
Q2 | $14.1M | Buy |
+225,578
| New | +$14.3M | 0.24% | 56 |
|
Other funds holding GSK
JEST
Jane Street's GSK Position: Q1 2026 in Review
Jane Street reduced its GSK (GSK) stake by 38% in Q1 2026, selling an estimated $22.3M and leaving 661,399 shares worth $36.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1272.
Jane Street first reported a position in GSK in Q2 2013 and has held it in 45 quarters since. The position peaked at $107M in Q3 2019. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.
- Jane Street held 661,399 shares of GSK worth $36.5M as of Q1 2026.
- Jane Street sold 411,956 GSK shares in Q1 2026, an estimated $22.3M.
- GSK made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #1272 holding.
- Jane Street first reported a position in GSK in Q2 2013 and has held it in 45 quarters since.
- Jane Street's GSK position peaked at $107M in Q3 2019.
- 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.
Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.